AVITA Medical (RCEL) Payables (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Payables data on file, last reported at $9.0 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 42.34% year-over-year to $9.0 million; the trailing twelve-month figure through Dec 2025 stood at $9.0 million (up 42.34% YoY), and the FY2025 full-year result was $9.0 million, up 42.34% from the prior year.
• Payables for Q4 2025 stood at $9.0 million, up from $8.1 million in the prior quarter.
• Across five years, Payables topped out at $9.0 million in Q4 2025 and bottomed at $2.4 million in Q1 2022.
• The 5-year median for Payables is $3.8 million (2023), against an average of $4.5 million.
• The widest annual swing landed in 2022, when Payables sank 34.11%; it then soared 93.81% in 2025.
• A 5-year view of Payables shows it stood at $2.7 million in 2021, then advanced by 10.86% to $3.0 million in 2022, then advanced by 26.35% to $3.8 million in 2023, then soared by 65.94% to $6.3 million in 2024, then jumped by 42.34% to $9.0 million in 2025.
• The last three Payables figures came in at $9.0 million (Q4 2025), $8.1 million (Q3 2025), and $7.3 million (Q2 2025), per Business Quant data.

Peer Comparison